why choose us

First received: November 10, 2023

Clinical Trial: Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ewing Sarcoma

Study Type: INTERVENTIONAL


Official Title: A Phase I Trial of Cabozantinib (XL184) in Combination With High-dose Ifosfamide in Adults and Children With Relapsed/Refractory Ewing Sarcoma and Osteosarcoma

Brief Summary: The purpose of this study is to better understand how safe and effective the drug cabozantinib in combination with high-dose ifosfamide is in the treatment of children and adults with relapsed/refractory Ewing sarcoma and osteosarcoma.

Read more